Acetylation phenotype in colorectal carcinomaILETT, K. F; DAVID, B. M; DETCHON, P et al.Cancer research (Baltimore). 1987, Vol 47, Num 5, pp 1466-1469, issn 0008-5472Article

Conséquences cliniques du polymorphisme génétique de la N-acetylation = Clinical significance of N-acétylation genetic polymorphismPRALONG, E; GASCON, M.-P; DAYER, P et al.Médecine et hygiène. 1986, Vol 44, Num 1653, pp 1162-1170, issn 0025-6749Article

Acetylation phenotype in abstinent alcoholicsGUTHRIE, S. K; LANE, E. A; LINNOILA, M et al.Alcoholism, clinical and experimental research. 1989, Vol 13, Num 1, pp 66-68, issn 0145-6008Article

Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2)TAKAHASHI, Kazutoshi; MAMYAMA, Masayoshi; TOKUZAWA, Yoshimi et al.Genomics (San Diego, Calif.). 2005, Vol 85, Num 3, pp 360-371, issn 0888-7543, 12 p.Article

Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamsterHEIN, D. W; KIRLIN, W. G; FERGUSON, R. J et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 2, pp 358-374, issn 0022-3565Article

A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotypeKUZNETSOV, Igor B; MCDUFFIE, Michael; MOSLEHI, Roxana et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 9, pp 1185-1186, issn 1367-4803, 2 p.Article

A simple test for acetylator phenotype using caffeine. Commentary. Authors' replyGRANT, D. M; TANG, B. K; KALOW, W et al.British journal of clinical pharmacology. 2004, Vol 58, Num 7, pp S788-S795, issn 0306-5251Article

A competitive enzyme linked immunosorbent assay for the determination of N-acetyltransferase (NAT2) phenotypesWONG, P; LEYLAND-JONES, B; WAINER, I. W et al.Journal of pharmaceutical and biomedical analysis. 1995, Vol 13, Num 9, pp 1079-1086, issn 0731-7085Article

The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a south-east Asian population : a study of Indians, Malays and Malaysian ChineseMEI LIN ONG; MANT, T. G. K; VEERAPEN, K et al.British journal of rheumatology. 1990, Vol 29, Num 6, pp 462-464, issn 0263-7103Article

Polymorphic N-acetylation capacity in lung cancerPHILIP, P. A; FITZGERALD, D. L; CARTWRIGHT, R. A et al.Carcinogenesis (New York. Print). 1988, Vol 9, Num 3, pp 491-493, issn 0143-3334Article

Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosusBAER, A. N; WOOSLEY, R. L; PINCUS, T et al.Arthritis and rheumatism. 1986, Vol 29, Num 4, pp 508-514, issn 0004-3591Article

N-acetylation pharmacogenetics: Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivoANDRES, H. H; WEBER, W. W.Drug metabolism and disposition. 1986, Vol 14, Num 4, pp 382-385, issn 0090-9556Article

Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoinBAUMANN, P; BOSSHART, P; GABRIS, G et al.Arzneimittel-Forschung. 1988, Vol 38, Num 2, pp 292-296, issn 0004-4172Article

High incidence of the slow nitrazepam acetylator phenotype in a Nigerian populationEZE(L. C.).Biochemical genetics. 1987, Vol 25, Num 3-4, pp 225-229, issn 0006-2928Article

Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotypeYAMAMOTO, T; SUOU, T; HIRAYAMA, C et al.Hepatology (Baltimore, Md.). 1986, Vol 6, Num 2, pp 295-298, issn 0270-9139Article

Ion-pair high-performance liquid chromatographic determination of isoniazid and acetylisoniazid in plasma and urine: application for acetylator phenotypingSVENSSON, J.-O; MUCHTAR, A; ERICSSON, O et al.Journal of chromatography. 1985, Vol 341, Num 1, pp 193-197, issn 0021-9673Article

Relationship between antipyrine metabolism and acetylation phenotype in health and chronic liver diseasesEL-YAZIGI, A; RAINES, D. A; FIDA ABDEL WAHAB et al.Journal of clinical pharmacology. 1995, Vol 35, Num 6, pp 615-621, issn 0091-2700Article

Acetylation pharmacogenetics: the slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liverGRANT, D. M; MÖRIKE, K; EICHELBAUM, M et al.The Journal of clinical investigation. 1990, Vol 85, Num 3, pp 968-972, issn 0021-9738Article

Drug acetylator phenotypes in newborn infantsSZORADY, I; SANTA, A; VERESS, I et al.Biological research in pregnancy and perinatology. 1987, Vol 8, Num 1, pp 23-25, issn 0724-438XArticle

Metabolism of hydralazine in man. II: Investigation of features relevant to drug safetyDUBOIS, J. P; SCHMID, K; RIESS, W et al.Arzneimittel-Forschung. 1987, Vol 37, Num 2, pp 189-193, issn 0004-4172Article

Determination of isoniazid half-life from salivary samplesSURYAWATI, S; SANTOSO, B.International journal of clinical pharmacology, therapy and toxicology (1980). 1986, Vol 24, Num 1, pp 18-22, issn 0174-4879Article

Acetylation phenotype and skin complexionRAMPEN, F. H. J; VAN DER MEEREN, H. L. M; STOLK, L. M. L et al.Acta dermato-venereologica. 1986, Vol 66, Num 4, pp 334-336, issn 0001-5555Article

Biomarkers in toxicologyTIMBRELL, J. A.Toxicology (Amsterdam). 1998, Vol 129, Num 1, pp 1-12, issn 0300-483XConference Paper

Ethnic differences in drug disposition and responseWOOD, A. J. J.Therapeutic drug monitoring. 1998, Vol 20, Num 5, pp 525-526, issn 0163-4356Conference Paper

Comparison of isoniazid phenotyping methods and acetylator distribution in 43 native Korean subjectsSHIN, J. G; SHIN, S. G; JANG, I. J et al.Asia pacific journal of pharmacology. 1992, Vol 7, Num 1, pp 1-8, issn 0217-9687Article